|
PBX2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.383000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.018700E-03 |
| Normal-vs-Stage2 |
1.155710E-03 |
| Normal-vs-Stage3 |
3.73169999999812E-05 |
| Normal-vs-Stage4 |
3.680900E-03 |
| Stage1-vs-Stage2 |
1.671590E-01 |
| Stage1-vs-Stage3 |
2.512000E-02 |
| Stage1-vs-Stage4 |
4.642600E-01 |
| Stage2-vs-Stage3 |
8.130400E-01 |
| Stage2-vs-Stage4 |
4.534800E-01 |
| Stage3-vs-Stage4 |
2.509400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.832100E-04 |
| Normal-vs-AfricanAmerican |
3.194200E-01 |
| Normal-vs-Asian |
4.778300E-02 |
| Caucasian-vs-AfricanAmerican |
2.638400E-01 |
| Caucasian-vs-Asian |
4.589600E-01 |
| AfricanAmerican-vs-Asian |
5.697800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.856400E-03 |
| Normal-vs-Female |
2.585500E-04 |
| Male-vs-Female |
7.570600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.102250E-02 |
| Normal-vs-Age(41-60Yrs) |
6.184200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.809200E-04 |
| Normal-vs-Age(81-100Yrs) |
3.431800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.612200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.060370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.762000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.284200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.155600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.412600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.02889999970191E-07 |
| Classical-VS-Follicular |
3.392600E-04 |
| Classical-VS-Other |
9.363800E-01 |
| Classical-VS-Normal |
4.694300E-02 |
| Tall-VS-Follicular |
4.246000E-01 |
| Tall-VS-Other |
9.802000E-03 |
| Tall-VS-Normal |
3.65719999839698E-08 |
| Follicular-VS-Other |
2.262400E-01 |
| Follicular-VS-Normal |
1.72671999999485E-05 |
| Other-VS-Normal |
4.480000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22129999999376E-05 |
| Normal-vs-N1 |
3.217700E-02 |
| N0-vs-N1 |
1.642210E-01 |
|
|
